ADB approves $450m loan to Indonesia to deliver safe COVID-19 vaccines
The Responsive COVID-19 Vaccines for Recovery (RECOVER) project will fund the purchase of at least 65 million doses of COVID-19 vaccine for priority groups determined by the Indonesian government. ADB | Manila | Updated: 31-03-2021 20:44 IST | Created: 31-03-2021 20:44 IST
The Indonesian government aims to vaccinate 181.5 million people against COVID-19 in one of the world’s biggest vaccination campaigns. Image Credit: ANI
The Asian Development Bank (ADB) has approved a $450 million loan to Indonesia to help Bio Farma, a state-owned vaccine supplier, procure and deliver safe and effective vaccines against the coronavirus disease (COVID-19).
The Philippines today became the first recipient of financing support under ADB's Asia Pacific Vaccine Access Facility with approval of a $400 million loan that will help the country purchase safe and effective vaccines against COVID-19.
By TED CORDERO, GMA News
Published March 12, 2021 10:37am
Updated March 12, 2021 11:04am The Asian Development Bank on Friday announced its approval of a $400-million loan to help the Philippines purchase vaccines against the coronavirus disease 2019 (COVID-19). In a statement, the Manila-based multilateral lender said the Philippines became the first recipient of financing support under its Asia Pacific Vaccine Access Facility (APVAX). “ADB’s support will boost the Philippine government’s urgent efforts to secure and deploy COVID-19 vaccines for all Filipinos, especially those who are vulnerable, such as frontline workers, the elderly, and poor and marginalized populations, as well as those at increased risk of severe illness,” said ADB President Masatsugu Asakawa.
Update: February, 23/2021 - 11:02 | Oxford/AstraZeneca COVID-19 vaccines are used in the WHO-led Vaccines Global Access (COVAX) initiative, to which Việt Nam is a recipient country. AFP/VNA Photo HÀ NỘI With the first COVID-19 vaccine doses slated to arrive in the country later this month, the Vietnamese health ministry has issued its initial vaccination rollout plan, including the priority groups to be given the jabs. The vaccines are from the WHO-led Vaccines Global Access (COVAX) initiative, created mainly to ensure supplies for developing countries. Việt Nam as an eligible recipient is set to receive 30 million doses throughout 2021.
The third phase could run concurrently with phase two depending on the availability of vaccines. The Ministry is targeting to vaccinate 4.9 million people during this period.
The vaccines, he says, will be a mix of AstraZeneca, Pfizer, Johnson and Johnson, and any other included in the COVAX facility.
He assured those wary of the vaccines that they have been tested and approved by the Stringent Regulatory Authority (SRA) and are safe for use.
“There are many misconceptions about the Covid-19 vaccines that may lead to vaccination hesitancy. Any adverse effects reported will be investigated and corrective measures are taken up immediately,” he continued.